What POA Pharma does

POA Pharma is a Denmark-headquartered pharmaceutical entity incorporated in 2011, currently operating with a reported headcount of 7 employees. Its registered office is in Birkerød, Denmark, and it maintains a web presence at poapharma.de, though the website returned only a loading/verification page at the time of data collection, indicating either a minimal public presence or a site-gating/anti-bot mechanism that prevented content extraction.

No products, services, technology stack, pricing model, customer segments, or distribution channels are documented in the available source material. The schema fields for core technology, proprietary features, value proposition, certifications, partnerships, and customer logos are all empty. The only first-party technical signal is a recorded API existence flag of "false", suggesting no externally consumable technical surface or platform play.

Consequently, the business model cannot be characterized from the supplied data. There is no revenue disclosed, no funding history, no management team enumerated, no M&A activity, and no regulatory actions recorded. POA Pharma appears to be a small, privately held Danish pharmaceutical company with no public commercial footprint visible in the aggregated sources — a profile that limits any analytical conclusion to the facts of its incorporation, location, and scale.

Name

POA Pharma

Website

https://poapharma.de

Company type

Private

Headcount range

1–10 employees

Short description

POA Pharma is a privately held Danish pharmaceutical company founded in 2011 and headquartered in Birkerød, Denmark, operating with approximately 7 employees. No products, customers, or revenue model are publicly disclosed in the available source data.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

Keywords

• Pharmaceutical products
• Specialty pharma
• Drug distribution
• Pharmaceutical sales
• Pharma company

GTM type

B2B

Offering type

Hardware or Manufacturing

Core offering

POA Pharma operates as a pharmaceutical company based in Birkerød, Denmark. No specific product portfolio, therapeutic areas, or service descriptions were evidenced in the available source data, as the company's website was not accessible for content extraction.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Regional players

• Almirall: Almirall is a European specialty pharmaceutical company focused on dermatology and other specialty therapy areas, commercialized across Europe through its own salesforce and partners. Comparable as a European specialty pharma distributor with focused therapy-area portfolios.
• Galenica Group: Galenica is a Swiss pharmaceutical and healthcare group with both wholesale/logistics and retail pharmacy businesses. Comparable as a European specialty pharma and pharmacy distribution operator with overlapping drug distribution activities.

Broad incumbents

• Orion Corporation: Orion is a Finnish pharmaceutical company that develops, manufactures, and markets specialty pharmaceuticals and active pharmaceutical ingredients across the Nordics and Europe. Comparable as a Nordic-rooted specialty pharma company with proprietary and partnered products sold through hospital and pharmacy channels.
• Swedish Orphan Biovitrum (Sobi): Sobi is a Nordic-headquartered specialty biopharma company focused on rare diseases and specialty care products distributed primarily through hospital and specialty pharmacy channels. It is comparable as a larger, incumbent Nordic specialty pharma player operating in overlapping therapeutic and distribution categories.
• Hikma Pharmaceuticals: Hikma is a multinational specialty pharmaceutical company that develops and markets branded and generic specialty products, including hospital injectables, across Europe, MENA, and the US. Comparable as a specialty pharma company distributing through hospital and pharmacy channels in overlapping European geographies.
• STADA Arzneimittel: STADA is a major European specialty and generics pharmaceutical company with broad distribution into pharmacies and hospitals across the continent. Comparable as a European specialty pharma distributor with a multi-country commercial footprint and focus on niche therapeutics.
• Mundipharma: Mundipharma is a global specialty pharmaceutical company that partners and distributes pain, oncology, and respiratory products across international markets through a network of associated companies. Comparable as a specialty pharma distributor operating via a decentralized, country-partner model in Europe.
• Recordati: Recordati is a European specialty pharmaceutical group focused on niche and rare disease treatments, distributed through its own commercial infrastructure across multiple European countries. Comparable as a pan-European specialty pharma company with similar hospital/specialty distribution mechanics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/poa-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about POA Pharma